Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1989-01-24
1992-01-21
Wax, Robert A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 23, A01N 43, A01N, A01N 3170, C07H 1702
Patent
active
050828290
ABSTRACT:
Prodrugs of AICA riboside are provided which increase the bioavailability of AICA riboside and thereby increase extracellular concentrations of the prophylactic and affirmative treatment of various pathologic conditions, including ischemia. Also provided are methods of using AICA riboside prodrugs in treating such conditions.
REFERENCES:
patent: 3910885 (1975-10-01), Moffatt
patent: 4575498 (1986-03-01), Holmes
patent: 4912092 (1990-03-01), Gruber
CA 83(21): 179457t (1975), J. Org. Chem. 40(20) Srivastava "Nucleosides of 4-Substituted Imidazoles".
CA 86(13): 90175p (1976) Chem. Pharm. Bull. 24(9) Miyoshi "Synthesis of 5-Amino-1-(3'-Deoxy-B-D) . . ."
CA 109(19): 170789a (1988) Nucleosides Nucleotides 7(3) chambers "Studies in the Protection & Deprotection . . ."
Browne Clinton E.
Gruber Harry E.
Reich Jack W.
Vgarkar Bheemaro G.
Gensia Pharmaceuticals
Tsung Fred
Wax Robert A.
LandOfFree
AICA riboside prodrugs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with AICA riboside prodrugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and AICA riboside prodrugs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-115668